Literature DB >> 21581718

(Z)-5-Fluoro-3-[(1H-pyrrol-2-yl)methyl-ene]indolin-2-one.

Hongming Zhang1, Haribabu Ankati, Shashidhar Kumar Akubathini, Ed Biehl.   

Abstract

The title compound, C(13)H(9)FN(2)O, a potential neuroprotective agent, consists of an indolinone and a pyrrolyl unit [dihedral angle between the ring planes = 4.9 (1)°]. An intra-molecular hydrogen bond between the carbonyl O atom and the NH group of pyrrole correlates with the Z arrangement of the substituents at the C=C bond. In the crystal, inversion dimers occur, linked by pairs of N-H⋯O bonds.

Entities:  

Year:  2008        PMID: 21581718      PMCID: PMC2967860          DOI: 10.1107/S1600536808040178

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For 3-substituted indole-2-one derivatives tested as protein kinase inhibitors, see: Sun et al. (2003 ▶). For derivatives with anti­tumor activity, see: Andreani et al. (2006 ▶). For derivatives with neuroprotective properties, see: Balderamos et al. (2008 ▶); Johnson et al. (2005 ▶). For related structures, see: Ali et al. (2008 ▶); De (2008 ▶); Zhang et al. (2008 ▶).

Experimental

Crystal data

C13H9FN2O M = 228.22 Monoclinic, a = 7.6093 (5) Å b = 6.1270 (4) Å c = 22.8912 (16) Å β = 91.390 (1)° V = 1066.92 (12) Å3 Z = 4 Mo Kα radiation μ = 0.10 mm−1 T = 293 (2) K 0.35 × 0.24 × 0.08 mm

Data collection

Bruker APEX diffractometer Absorption correction: multi-scan (SADABS; Sheldrick, 1996 ▶) T min = 0.964, T max = 0.992 12282 measured reflections 2552 independent reflections 2167 reflections with I > 2σ(I) R int = 0.022

Refinement

R[F 2 > 2σ(F 2)] = 0.054 wR(F 2) = 0.137 S = 1.10 2552 reflections 154 parameters H-atom parameters constrained Δρmax = 0.23 e Å−3 Δρmin = −0.22 e Å−3 Data collection: SMART (Bruker, 1997 ▶); cell refinement: SAINT (Bruker, 1997 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL and publCIF (Westrip, 2008 ▶). Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536808040178/si2132sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536808040178/si2132Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C13H9FN2OF(000) = 472
Mr = 228.22Dx = 1.421 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
a = 7.6093 (5) ÅCell parameters from 3595 reflections
b = 6.1270 (4) Åθ = 2.7–25.4°
c = 22.8912 (16) ŵ = 0.10 mm1
β = 91.390 (1)°T = 293 K
V = 1066.92 (12) Å3Plates, orange
Z = 40.35 × 0.24 × 0.08 mm
Bruker APEX diffractometer2552 independent reflections
Radiation source: fine-focus sealed tube2167 reflections with I > 2σ(I)
graphiteRint = 0.022
Detector resolution: 83.33 pixels mm-1θmax = 28.3°, θmin = 1.8°
φ and ω scansh = −9→9
Absorption correction: multi-scan (SADABS; Sheldrick, 1996)k = −8→8
Tmin = 0.964, Tmax = 0.992l = −29→29
12282 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.054Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.137H-atom parameters constrained
S = 1.10w = 1/[σ2(Fo2) + (0.0587P)2 + 0.3105P] where P = (Fo2 + 2Fc2)/3
2552 reflections(Δ/σ)max < 0.001
154 parametersΔρmax = 0.23 e Å3
0 restraintsΔρmin = −0.22 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
N10.36941 (18)0.7704 (2)−0.02026 (6)0.0462 (3)
H10.41560.8783−0.03840.055*
C20.3608 (2)0.7558 (3)0.03865 (7)0.0422 (4)
O20.41973 (16)0.89761 (19)0.07266 (5)0.0515 (3)
C30.27094 (19)0.5468 (2)0.05187 (7)0.0395 (3)
C40.1488 (2)0.2559 (3)−0.02156 (7)0.0457 (4)
H40.10590.15910.00600.055*
C50.1325 (2)0.2144 (3)−0.08055 (8)0.0503 (4)
F50.04936 (17)0.0275 (2)−0.09798 (5)0.0727 (4)
C60.1934 (2)0.3515 (3)−0.12313 (7)0.0536 (4)
H60.17880.3157−0.16240.064*
C70.2772 (2)0.5443 (3)−0.10659 (7)0.0511 (4)
H70.32040.6399−0.13430.061*
C80.2942 (2)0.5888 (3)−0.04789 (7)0.0421 (4)
C90.23179 (19)0.4481 (2)−0.00504 (6)0.0395 (3)
C100.2305 (2)0.4604 (3)0.10429 (7)0.0448 (4)
H100.17710.32410.10190.054*
N110.3347 (2)0.7320 (3)0.17745 (6)0.0587 (4)
H110.38190.82150.15350.070*
C120.2548 (2)0.5398 (3)0.16222 (7)0.0488 (4)
C130.1974 (3)0.4470 (4)0.21346 (8)0.0667 (6)
H130.13900.31440.21670.080*
C140.2423 (4)0.5862 (4)0.25906 (9)0.0792 (7)
H140.21840.56540.29830.095*
C150.3282 (4)0.7598 (4)0.23562 (9)0.0756 (7)
H150.37460.87770.25640.091*
U11U22U33U12U13U23
N10.0597 (8)0.0390 (7)0.0402 (7)−0.0043 (6)0.0079 (6)0.0063 (5)
C20.0462 (8)0.0393 (8)0.0414 (8)0.0013 (6)0.0063 (6)0.0043 (6)
O20.0673 (8)0.0445 (6)0.0431 (6)−0.0124 (5)0.0075 (5)−0.0007 (5)
C30.0408 (7)0.0384 (8)0.0395 (8)0.0016 (6)0.0050 (6)0.0011 (6)
C40.0496 (9)0.0423 (9)0.0453 (9)−0.0009 (7)0.0042 (7)0.0017 (7)
C50.0562 (10)0.0442 (9)0.0505 (10)0.0006 (7)−0.0014 (7)−0.0068 (7)
F50.0964 (9)0.0608 (7)0.0608 (7)−0.0194 (6)−0.0027 (6)−0.0137 (6)
C60.0669 (11)0.0565 (10)0.0374 (8)0.0071 (9)−0.0002 (7)−0.0055 (7)
C70.0663 (11)0.0503 (10)0.0370 (8)0.0057 (8)0.0066 (7)0.0063 (7)
C80.0465 (8)0.0390 (8)0.0409 (8)0.0055 (6)0.0036 (6)0.0038 (6)
C90.0411 (7)0.0401 (8)0.0374 (8)0.0053 (6)0.0047 (6)0.0027 (6)
C100.0473 (8)0.0448 (9)0.0425 (9)−0.0051 (7)0.0041 (6)0.0037 (7)
N110.0806 (11)0.0554 (9)0.0404 (8)−0.0147 (8)0.0106 (7)0.0001 (6)
C120.0545 (9)0.0523 (10)0.0398 (9)−0.0033 (7)0.0046 (7)0.0045 (7)
C130.0903 (15)0.0664 (13)0.0436 (10)−0.0170 (11)0.0087 (9)0.0076 (9)
C140.124 (2)0.0762 (15)0.0380 (10)−0.0175 (14)0.0131 (11)0.0031 (9)
C150.1179 (18)0.0673 (13)0.0420 (10)−0.0167 (13)0.0082 (11)−0.0050 (9)
N1—C21.355 (2)C7—C81.374 (2)
N1—C81.396 (2)C7—H70.9300
N1—H10.8600C8—C91.397 (2)
C2—O21.2429 (19)C10—C121.421 (2)
C2—C31.486 (2)C10—H100.9300
C3—C101.354 (2)N11—C151.344 (2)
C3—C91.460 (2)N11—C121.367 (2)
C4—C51.377 (2)N11—H110.8600
C4—C91.385 (2)C12—C131.384 (2)
C4—H40.9300C13—C141.385 (3)
C5—F51.364 (2)C13—H130.9300
C5—C61.376 (3)C14—C151.365 (3)
C6—C71.390 (3)C14—H140.9300
C6—H60.9300C15—H150.9300
C2—N1—C8111.66 (13)N1—C8—C9108.45 (14)
C2—N1—H1124.2C4—C9—C8119.57 (14)
C8—N1—H1124.2C4—C9—C3132.66 (14)
O2—C2—N1123.50 (14)C8—C9—C3107.77 (14)
O2—C2—C3129.46 (14)C3—C10—C12131.79 (16)
N1—C2—C3107.04 (14)C3—C10—H10114.1
C10—C3—C9125.66 (15)C12—C10—H10114.1
C10—C3—C2129.26 (15)C15—N11—C12109.57 (16)
C9—C3—C2105.08 (13)C15—N11—H11125.2
C5—C4—C9117.01 (15)C12—N11—H11125.2
C5—C4—H4121.5N11—C12—C13106.60 (16)
C9—C4—H4121.5N11—C12—C10125.47 (15)
F5—C5—C6117.86 (15)C13—C12—C10127.88 (17)
F5—C5—C4118.16 (16)C12—C13—C14107.97 (19)
C6—C5—C4123.97 (16)C12—C13—H13126.0
C5—C6—C7119.06 (15)C14—C13—H13126.0
C5—C6—H6120.5C15—C14—C13107.19 (18)
C7—C6—H6120.5C15—C14—H14126.4
C8—C7—C6117.81 (15)C13—C14—H14126.4
C8—C7—H7121.1N11—C15—C14108.66 (19)
C6—C7—H7121.1N11—C15—H15125.7
C7—C8—N1128.97 (15)C14—C15—H15125.7
C7—C8—C9122.58 (15)
D—H···AD—HH···AD···AD—H···A
N1—H1···O2i0.862.032.8711 (17)166
N11—H11···O20.861.942.6977 (19)147
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N1—H1⋯O2i0.862.032.8711 (17)166
N11—H11⋯O20.861.942.6977 (19)147

Symmetry code: (i) .

  8 in total

1.  Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase.

Authors:  Li Sun; Chris Liang; Sheri Shirazian; Yong Zhou; Todd Miller; Jean Cui; Juri Y Fukuda; Ji-Yu Chu; Asaad Nematalla; Xueyan Wang; Hui Chen; Anand Sistla; Tony C Luu; Flora Tang; James Wei; Cho Tang
Journal:  J Med Chem       Date:  2003-03-27       Impact factor: 7.446

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Inhibition of neuronal apoptosis by the cyclin-dependent kinase inhibitor GW8510: identification of 3' substituted indolones as a scaffold for the development of neuroprotective drugs.

Authors:  Kyle Johnson; Li Liu; Nazanin Majdzadeh; Cindy Chavez; Paul C Chin; Brad Morrison; Lulu Wang; Jane Park; Priti Chugh; Hsin-Mei Chen; Santosh R D'Mello
Journal:  J Neurochem       Date:  2005-05       Impact factor: 5.372

4.  Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1.

Authors:  Aldo Andreani; Silvia Burnelli; Massimiliano Granaiola; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi; Lucilla Varoli; Mark W Kunkel
Journal:  J Med Chem       Date:  2006-11-16       Impact factor: 7.446

5.  Synthesis and structure-activity relationship studies of 3-substituted indolin-2-ones as effective neuroprotective agents.

Authors:  Michael Balderamos; Haribabu Ankati; Shashidhar Kumar Akubathini; Anish V Patel; Sukanta Kamila; Chandrani Mukherjee; Lulu Wang; Edward R Biehl; Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2008-11

6.  (E)-5-Chloro-3-(2,6-dichloro-benzyl-idene)-indolin-2-one.

Authors:  Hongming Zhang; Haribabu Ankati; Shashidhar Kumar Akubathini; Ed Biehl
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-10-11

7.  5'-Chloro-spiro-[1,3-dioxolane-2,3'-indolin]-2'-one: a potential anti-convulsant.

Authors:  Amitabha De
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-02-06

8.  N'-(5-Fluoro-2-oxo-2,3-dihydro-1H-indol-3-yl-idene)benzene-sulfono-hydrazide.

Authors:  Hapipah M Ali; Musalem Laila; Mohd Razali Rizal; Seik Weng Ng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-04-26
  8 in total
  3 in total

1.  (E)-5-Bromo-3-(2,6-dichloro-benzyl-idene)indolin-2-one.

Authors:  Hongming Zhang; Haribabu Ankati; Shashidhar Kumar Akubathini; Ed Biehl
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-08-22

2.  (E)-3-(2,6-Dichloro-benzyl-idene)indolin-2-one.

Authors:  Hongming Zhang; Haribabu Ankati; Ed Biehl
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-28

3.  (Z)-3-[(E)-3-Phenyl-allyl-idene]indolin-2-one.

Authors:  Hongming Zhang; Shashidhar Kumar Akubathini; Haribabu Ankati; Ed Biehl
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-01-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.